Grown Rogue International (GRUSF) Net Cash Flow Growth (3y) (2016 - 2023)
Grown Rogue International (GRUSF) Net Cash Flow Growth (3y) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 32.03% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 28.99% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -49.94% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -41.05% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -62.71% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -205.66% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -59.10% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 36.11% |
| 10 | Grown Rogue International | - | - | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | 109.67% |
| Apr 30, 2022 | -38.79% |
| Jan 31, 2022 | 73.29% |
| Oct 31, 2021 | 7,801.48% |
| Jul 31, 2021 | -12,833.61% |
| Apr 30, 2021 | 60.30% |
| Jan 31, 2021 | 5.26% |
| Aug 31, 2018 | 32.96% |
| May 31, 2018 | 60.68% |
| Feb 28, 2018 | 111.26% |
| Aug 31, 2017 | 65.28% |
| May 31, 2017 | -74.75% |
| Feb 28, 2017 | -35.00% |
| Nov 30, 2016 | -35.23% |
| Aug 31, 2016 | 35.89% |